Alendronate/lactoferrin-dual decorated lipid nanocarriers for bone-homing and active targeting of ivermectin and methyl dihydrojasmonate for leukemia
Biomaterials Advances · 2024
DOI: 10.1016/j.bioadv.2024.213924 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Advances, 2024. Verfasst von Fatma S Abou-Elnour und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt. Hauptthemen laut MEDLINE: Drug Carriers, Lactoferrin, Alendronate, Ivermectin. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 81 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.
- Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt. Electronic address: salma.elhaleem@alexu.edu.eg.
- Department of Oral Pathology, Faculty of Dentistry, Alexandria University, Alexandria, Egypt; Center of Excellence for Research in Regenerative Medicine and Applications (CERRMA), Faculty of Medicine, Alexandria Univers…
Zitieren
APA
Abou-Elnour, F. S., El-Habashy, S. E., Essawy, M. M., & Abdallah, O. Y. (2024). Alendronate/lactoferrin-dual decorated lipid nanocarriers for bone-homing and active targeting of ivermectin and methyl dihydrojasmonate for leukemia. Biomaterials Advances. https://doi.org/10.1016/j.bioadv.2024.213924
Vancouver
Abou-Elnour FS, El-Habashy SE, Essawy MM, Abdallah OY. Alendronate/lactoferrin-dual decorated lipid nanocarriers for bone-homing and active targeting of ivermectin and methyl dihydrojasmonate for leukemia. Biomaterials Advances. 2024. doi:10.1016/j.bioadv.2024.213924
BibTeX
@article{AbouElnour2024,
author = {Abou-Elnour, Fatma S and El-Habashy, Salma E and Essawy, Marwa M and Abdallah, Ossama Y},
title = {Alendronate/lactoferrin-dual decorated lipid nanocarriers for bone-homing and active targeting of ivermectin and methyl dihydrojasmonate for leukemia},
journal = {Biomaterials Advances},
year = {2024},
doi = {10.1016/j.bioadv.2024.213924}
}
EUVIMED